1 September 2024 false No description of principal activity Taxfiler 2024.6 09734615business:PrivateLimitedCompanyLtd2024-09-012025-08-31 097346152024-08-31 097346152024-09-012025-08-31 09734615business:AuditExempt-NoAccountantsReport2024-09-012025-08-31 09734615business:FilletedAccounts2024-09-012025-08-31 097346152025-08-31 09734615business:Director12024-09-012025-08-31 09734615business:CompanySecretary12024-09-012025-08-31 09734615business:RegisteredOffice2024-09-012025-08-31 097346152024-08-31 09734615core:WithinOneYear2025-08-31 09734615core:WithinOneYear2024-08-31 09734615core:AfterOneYear2025-08-31 09734615core:AfterOneYear2024-08-31 09734615core:ShareCapitalcore:PreviouslyStatedAmount2025-08-31 09734615core:ShareCapitalcore:PreviouslyStatedAmount2024-08-31 09734615core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-08-31 09734615core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-08-31 09734615core:PreviouslyStatedAmount2025-08-31 09734615core:PreviouslyStatedAmount2024-08-31 09734615business:SmallEntities2024-09-012025-08-31 09734615countries:EnglandWales2024-09-012025-08-31 09734615core:ComputerEquipment2024-09-012025-08-31 09734615core:ComputerEquipment2024-08-31 09734615core:ComputerEquipment2025-08-31 09734615core:AcceleratedTaxDepreciationDeferredTax2025-08-31 09734615core:AcceleratedTaxDepreciationDeferredTax2024-08-31 097346152023-08-31 097346152023-09-012024-08-31 iso4217:GBP xbrli:pure
Company Registration No. 09734615 (England and Wales)
Pharma Experts Limited Unaudited accounts for the year ended 31 August 2025
Pharma Experts Limited Unaudited accounts Contents
Page
- 2 -
Pharma Experts Limited Company Information for the year ended 31 August 2025
Director
Zulfikar Mamon
Secretary
Zulfikar Mamon
Company Number
09734615 (England and Wales)
Registered Office
Ground Floor, 4 King John House Kingsclere, Newbury, England, RG20 4SW England
- 3 -
Pharma Experts Limited Statement of financial position as at 31 August 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
17,752 
19,296 
Current assets
Debtors
22,341 
25,792 
Cash at bank and in hand
217,191 
200,668 
239,532 
226,460 
Creditors: amounts falling due within one year
(22,765)
(9,490)
Net current assets
216,767 
216,970 
Total assets less current liabilities
234,519 
236,266 
Creditors: amounts falling due after more than one year
(10,834)
(20,833)
Provisions for liabilities
Deferred tax
(4,437)
(4,136)
Net assets
219,248 
211,297 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
219,247 
211,296 
Shareholders' funds
219,248 
211,297 
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 3 April 2026 and were signed on its behalf by
Zulfikar Mamon Director Company Registration No. 09734615
- 4 -
Pharma Experts Limited Notes to the Accounts for the year ended 31 August 2025
1
Statutory information
Pharma Experts Limited is a private company, limited by shares, registered in England and Wales, registration number 09734615. The registered office is Ground Floor, 4 King John House, Kingsclere,, Newbury,, England,, RG20 4SW, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
15% Reducing Balance Basis
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 September 2024
45,407 
Additions
1,456 
At 31 August 2025
46,863 
Depreciation
At 1 September 2024
26,111 
Charge for the year
3,000 
At 31 August 2025
29,111 
Net book value
At 31 August 2025
17,752 
At 31 August 2024
19,296 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Accrued income and prepayments
22,276 
25,792 
Other debtors
65 
- 
22,341 
25,792 
- 5 -
Pharma Experts Limited Notes to the Accounts for the year ended 31 August 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Bank loans and overdrafts
- 
960 
VAT
2,494 
3,571 
Taxes and social security
2,613 
(165)
Other creditors
16,486 
- 
Loans from directors
102 
4,214 
Accruals
1,070 
910 
22,765 
9,490 
7
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Bank loans
10,834 
20,833 
8
Deferred taxation
2025 
2024 
£ 
£ 
Accelerated capital allowances
4,437 
4,136 
2025 
2024 
£ 
£ 
Provision at start of year
4,136 
4,136 
Charged to the profit and loss account
301 
- 
Provision at end of year
4,437 
4,136 
9
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 6 -